AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Index funds distribute capital gains at occasional dates; knowing when helps you coordinate withdrawals and tax planning effectively.
25,550 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Volkswagen signals the possibility of up to 50,000 additional job cuts, potentially bringing total reductions to as m...
A stock surged 125% in 2026, turning heads across the market. This deep-dive breaks down the drivers of the move, how...
Oil prices jump as geopolitical tensions intensify, setting up a potential upside for select energy stocks. Three nam...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
A global energy crunch tied to the Iran war is renewing talk of a permanent four-day workweek. Experts say the shift ...
A fresh study highlights a widening split among high earners. The k-shaped economy left many six-figure earners on th...
A rising labor union participation rise is reshaping the U.S. workforce, with more workers joining unions while emplo...
A three-year high in core inflation is stirring worry for seniors who rely on Social Security. Frozen tax thresholds ...
Solana is back in the spotlight as network upgrades and institutional interest pick up. The big question for investor...
The monthly nonfarm payrolls report is a big market event, but it can mislead if you lean on it without guarding agai...
A larger stock buyback authorization sent BlackLine's shares higher, signaling confidence from management. This analy...